Grufity logo
Grufity logo

Latest Medicxi Ventures Management (Jersey) Ltd Stock Portfolio

$981Million | No. of Holdings #4

Medicxi Ventures Management (Jersey) Ltd Performance

2026 Q1+33.50%
YTD+33.50%
2025+42.99%

About Medicxi Ventures Management (Jersey) Ltd and 13F Hedge Fund Stock Holdings

On 2026-04-21, the fund reported it's updated stock portfolio. In the 13F Holdings report, Medicxi Ventures Management (Jersey) Ltd reported an equity portfolio of $981.8 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Medicxi Ventures Management (Jersey) Ltd are CNTA, NAMS, PHAT. The fund has invested 80.8% of it's portfolio in CENTESSA PHARMACEUTICALS PLC and 8.7% of portfolio in NEWAMSTERDAM PHARMA COMPANY. <br><br> The fund managers got completely rid off RAPT THERAPEUTICS INC (RAPT) stocks. They significantly reduced their stock positions in NEWAMSTERDAM PHARMA COMPANY (NAMS).
Medicxi Ventures Management (Jersey) Ltd Equity Portfolio Value
Last Reported on: 21 Apr, 2026
$981Million
  as of Apr 21, 2026

Medicxi Ventures Management (Jersey) Ltd Annual Return Estimates Vs S&P 500

Our best estimate is that Medicxi Ventures Management (Jersey) Ltd made a return of 33.5% in the last quarter. In trailing 12 months, it's portfolio return was 130.73%.
  • Performance
  • S&P 500

New Buys

No new stocks were added by Medicxi Ventures Management (Jersey) Ltd

Additions

No additions were made to existing positions by Medicxi Ventures Management (Jersey) Ltd

Reductions

Ticker% Reduced
newamsterdam pharma company-6.81
Medicxi Ventures Management (Jersey) Ltd reduced stake in above stock

Sold off

Ticker$ Sold
rapt therapeutics inc-94,632,800
Medicxi Ventures Management (Jersey) Ltd got rid off the above stocks

Sector Distribution

Medicxi Ventures Management (Jersey) Ltd has about 91.3% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare91.3
Others8.7

Market Cap. Distribution

Medicxi Ventures Management (Jersey) Ltd has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • SMALL-CAP
  • UNALLOCATED
Category%
MID-CAP80.8
SMALL-CAP10.5
UNALLOCATED8.7

Stocks belong to which Index?

About 10.5% of the stocks held by Medicxi Ventures Management (Jersey) Ltd either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others89.5
RUSSELL 200010.5
Top 5 Winners (%)%
CNTA
centessa pharmaceuticals plc
58.8 %
AURA
aura biosciences inc
22.8 %
Top 5 Winners ($)$
CNTA
centessa pharmaceuticals plc
293.7 M
AURA
aura biosciences inc
3.8 M
Top 5 Losers (%)%
PHAT
phathom pharmaceuticals inc
-33.0 %
NAMS
newamsterdam pharma company
-8.4 %
Top 5 Losers ($)$
PHAT
phathom pharmaceuticals inc
-40.9 M
NAMS
newamsterdam pharma company
-8.5 M

Medicxi Ventures Management (Jersey) Ltd Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Medicxi Ventures Management (Jersey) Ltd

Medicxi Ventures Management (Jersey) Ltd has 4 stocks in it's portfolio. PHAT proved to be the most loss making stock for the portfolio. CNTA was the most profitable stock for Medicxi Ventures Management (Jersey) Ltd last quarter.

$981.81MTotal Value
5.00Positions
21 Apr, 2026Last Reported
Current holdings of Current Stock Holdings of Medicxi Ventures Management (Jersey) Ltd, last reported on 21 Apr, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
NAMS
Newamsterdam Pharma Company

Newamsterdam Pharma Company

NAMS
Medicxi Ventures Management (Jersey) Ltd's holding in Newamsterdam Pharma Company over time
8.72%2,674,180
$85.60M
8.72%
decreased 6.81 percentreduced